- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (712)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (622)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (882)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (596)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1764)
Mastectomy plus reconstruction equals rise in complication rates, costs
2 minute read | Published January 13, 2016
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on January 13, 2016
The 140,000 U.S. women diagnosed each year with early-stage breast cancer, when the tumor is still small and hasn’t spread, have a variety of treatment options. All offer similar survival rates when initiated in the early stages of the disease.
Yet in increasing numbers, women are choosing the most aggressive option — mastectomy followed by breast reconstruction.
A recent MD Anderson study suggests women may want to reconsider before undergoing such an extensive and expensive procedure.
The study found that mastectomy, when combined with breast reconstruction, carries a high risk of complications and a heavy financial cost resulting from those complications.
Researchers analyzed 10 years of medical claims data from more than 100,000 women with early-stage breast cancer. They divided study subjects into two groups — one group include women age 65 and younger who had private health insurance, and a second group consisted of Medicare enrollees older than 65.
The findings were surprising, says Benjamin Smith, M.D., associate professor of Radiation Oncology at MD Anderson and the study’s lead author.
More than half of younger patients who had a mastectomy plus reconstruction experienced complications, such as infection. For women age 65 and older who received the procedure, the complication rate was nearly 70 percent.
Lumpectomy, a procedure where the tumor is removed and the breast is spared, followed by radiation, had a complication rate ranging from about 30 to 45 percent among younger women.
“What we show for the first time is that patients who undergo more surgery are also taking on considerably more risk with regard to what could happen. If the patient can have a lumpectomy and radiation, it may be a smoother course than going through a mastectomy, reconstruction and potentially other surgeries,” explained Smith.
The study also analyzed the financial burden of complications. Smith and colleagues found that the cost of caring for complications resulting from mastectomy and reconstruction averaged $10,005. The costs for complications after lumpectomy and whole-breast irradiation averaged far less, at $1,397.
Smith believes this type of data will provide guidance for insurance companies as they start to think about bundled payments for breast cancer care.
Despite the findings, Smith stresses that for some patients with early breast cancer, mastectomy plus reconstruction is truly their best treatment option, and that these research findings shouldn't be used to decrease reimbursement or coverage when this procedure is medically indicated.
Read more about this study on MD Anderson’s website.
